Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Price to free cash flow ratio
Latest
-12.38
↑ 28% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-17.28
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -12.38 | +14.4% |
| 2024 | -14.46 | -80.6% |
| 2023 | -8.01 | -156.1% |
| 2022 | -3.13 | +14.1% |
| 2021 | -3.64 | +91.6% |
| 2020 | -43.07 | -265.9% |
| 2019 | -11.77 | +60.1% |
| 2018 | -29.53 | -0.1% |
| 2017 | -29.50 | - |